Per-procedural ablation zone imaging with MRI during radiofrequency ablation of locally irresectable pancreatic cancer

Withdrawn

• Conditions: pancreatic cancer; Pancreatic tumor; 10017991; 10017998

• Registration Number: NL-OMON45396
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Participation in PELICAN-trial and randomized for RFA-treatment

Exclusion Criteria

Contra-indications to undergo MR imaging
Impossibility to obtain informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome is to assess the feasibility of real-time MRI temperature<br /><br>monitoring during RFA of locally irresectable pancreatic cancer.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are assessment of correlation of per-procedural MRI-guided<br /><br>delineated zone of ablation with ablation effect on CT scan day 7 after RFA and<br /><br>verification on intraoperative MRI of the localization, distance to adjacent<br /><br>structures and position within the tumour of the ultrasound guidance placed<br /><br>needles.</p><br>